Amortization of Intangible Assets in USD of Ambrx Biopharma Cayman, Inc. from 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Amortization of Intangible Assets history and change rate from 2019 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Amortization of Intangible Assets for the quarter ending 30 Jun 2023 was $200,000.000, a 50% decline year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Amortization of Intangible Assets for 2022 was $1,052,000.000, a 34.4% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Amortization of Intangible Assets for 2021 was $1,604,000.000, a 10.5% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Amortization of Intangible Assets for 2020 was $1,451,000.000, unchanged from 2019.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $200,000 -$200,000 -50% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $157,000 -$211,000 -57.3% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q2 2022 $400,000 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $368,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023

Ambrx Biopharma Cayman, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1,052,000 -$552,000 -34.4% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023
2021 $1,604,000 +$153,000 +10.5% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 $1,451,000 $0 0% 01 Jan 2020 31 Dec 2020 20-F 26 Apr 2022
2019 $1,451,000 01 Jan 2019 31 Dec 2019 20-F 26 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.